William Garrett Nichols Candel Therapeutics, Inc. (CADL) insider trading activity

CADL Quotes by TradingView

William Garrett Nichols is Chief Medical Officer of Candel Therapeutics, Inc.. Currently has a direct ownership of 100,547 shares of CADL, which is worth approximately $879,786. The most recent transaction as insider was on Nov 29, 2024, when has been sold 13,935 shares (Common Stock) at a price of $4.56 per share, resulting in proceeds of $63,543. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 101K
12.17% 3M change
25.59% 12M change
Total Value Held $879,786

William Garrett Nichols Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 29 2024
SELL
Open market or private sale
$63,543 $4.56 p/Share
13,935 Reduced 12.17%
100,547 Common Stock
Jul 17 2024
SELL
Open market or private sale
$70,361 $6.47 p/Share
10,875 Reduced 8.68%
114,482 Common Stock
Jul 11 2024
SELL
Open market or private sale
$58,320 $5.97 p/Share
9,769 Reduced 7.23%
125,357 Common Stock
Nov 28 2023
SELL
Payment of exercise price or tax liability
$10,957 $0.9 p/Share
12,175 Reduced 8.27%
135,126 Common Stock
Nov 26 2023
BUY
Grant, award, or other acquisition
-
88,822 Added 37.62%
147,301 Common Stock
Nov 28 2022
BUY
Grant, award, or other acquisition
-
58,479 Added 50.0%
58,479 Common Stock
WGN

William Garrett Nichols

Chief Medical Officer
Needham, MA

Track Institutional and Insider Activities on CADL

Follow Candel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CADL shares.

Notify only if

Insider Trading

Get notified when an Candel Therapeutics, Inc. insider buys or sells CADL shares.

Notify only if

News

Receive news related to Candel Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CADL